| Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis JP Legg, IR Hussain, JA Warner, SL Johnston, JO Warner American journal of respiratory and critical care medicine 168 (6), 633-639, 2003 | 571 | 2003 |
| Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath C Lane, D Knight, S Burgess, P Franklin, F Horak, J Legg, A Moeller, ... Thorax 59 (9), 757-760, 2004 | 327 | 2004 |
| Low-dose nitric oxide as targeted anti-biofilm adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis RP Howlin, K Cathie, L Hall-Stoodley, V Cornelius, C Duignan, RN Allan, ... Molecular Therapy 25 (9), 2104-2116, 2017 | 195 | 2017 |
| Bronchiolitis in children: summary of NICE guidance V Ricci, VD Nunes, MS Murphy, S Cunningham Bmj 350, 2015 | 133 | 2015 |
| Frequency of detection of picornaviruses and seven other respiratory pathogens in infants JP Legg, JA Warner, SL Johnston, JO Warner The Pediatric infectious disease journal 24 (7), 611-616, 2005 | 116 | 2005 |
| Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week … S Sutharsan, EF McKone, DG Downey, J Duckers, G MacGregor, E Tullis, ... The Lancet Respiratory Medicine 10 (3), 267-277, 2022 | 83 | 2022 |
| Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis TWV Daniels, GB Rogers, FA Stressmann, CJ Van Der Gast, KD Bruce, ... Journal of Cystic Fibrosis 12 (1), 22-28, 2013 | 70 | 2013 |
| Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function … MA Mall, R Brugha, S Gartner, J Legg, A Moeller, P Mondejar-Lopez, ... American journal of respiratory and critical care medicine 206 (11), 1361-1369, 2022 | 67 | 2022 |
| Molecular microbiological characterization of preterm neonates at risk of bronchopulmonary dysplasia MS Payne, KCW Goss, GJ Connett, T Kollamparambil, JP Legg, ... Pediatric research 67 (4), 412-418, 2010 | 66 | 2010 |
| Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial K Pike, A Selby, S Price, J Warner, G Connett, J Legg, JSA Lucas, ... The clinical respiratory journal 7 (2), 204-213, 2013 | 55 | 2013 |
| Update on the causes, investigation and management of empyema in childhood W Walker, R Wheeler, J Legg Archives of disease in childhood 96 (5), 482-488, 2011 | 48 | 2011 |
| Using electronic referral with digital imaging between primary and secondary ophthalmic services: a long term prospective analysis of regional service redesign S Borooah, B Grant, A Blaikie, C Styles, S Sutherland, G Forrest, P Curry, ... Eye 27 (3), 392-397, 2013 | 35 | 2013 |
| A quantitative analysis of Ureaplasma urealyticum and Ureaplasma parvum compared with host immune response in preterm neonates at risk of developing bronchopulmonary dysplasia MS Payne, KCW Goss, GJ Connett, JP Legg, KD Bruce, V Chalker Journal of clinical microbiology 50 (3), 909-914, 2012 | 32 | 2012 |
| Will pneumococci put quinolones in their place? JM Legg, AJ Bint Journal of Antimicrobial Chemotherapy 44 (4), 425-427, 1999 | 30 | 1999 |
| Surgical correction of scoliosis in children with spastic quadriplegia: benefits, adverse effects, and patient selection J Legg, E Davies, AL Raich, JR Dettori, N Sherry Evidence-based spine-care journal 5 (01), 038-051, 2014 | 29 | 2014 |
| The use of culture-independent tools to characterize bacteria in endo-tracheal aspirates from pre-term infants at risk of bronchopulmonary dysplasia FA Stressmann, GJ Connett, K Goss, TG Kollamparambil, N Patel, ... Walter de Gruyter 38 (3), 333-337, 2010 | 26 | 2010 |
| 15-minute consultation: a structured approach to the assessment of chest pain in a child SA Collins, MJ Griksaitis, JP Legg Archives of Disease in Childhood-Education and Practice 99 (4), 122-126, 2014 | 23 | 2014 |
| The impact of 12 months treatment with ivacaftor on Scottish paediatric patients with cystic fibrosis with the G551D mutation: a review C Dryden, J Wilkinson, D Young, RJ Brooker Archives of Disease in Childhood 103 (1), 68-70, 2018 | 20 | 2018 |
| BTS clinical statement on aspiration pneumonia AJ Simpson, JL Allen, M Chatwin, H Crawford, J Elverson, V Ewan, ... Thorax 78 (Suppl 1), s3-s21, 2023 | 19 | 2023 |
| COVID‐19: impact, experiences, and support needs of children and young adults with cystic fibrosis and parents N Collaço, J Legg, M Day, D Culliford, A Campion, C West, AS Darlington Pediatric pulmonology 56 (9), 2845-2853, 2021 | 17 | 2021 |
